Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0RIM stock hub

LON/0RIM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RIMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RIM

In the news

Latest news · LON/0RIM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RIM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

EUR

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	13
Employees Change	-3%
Employees Change Percent	-18.75
Enterprise value	EUR 25.3M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 16.3M
Price	EUR 0.08
Price currency	EUR
Rev Per Employee	43,752.85x
Sic	2836
Symbol	lon/0RIM
Website	https://www.gensight-biologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-64.32%
EV Earnings	-2.41x
EV/FCF	-3.17x
EV/Sales	45.01x
FCF yield	-49.03%
P/B ratio	-0.75x
P/S ratio	28.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 568,787
Gross Profit Growth	-31.01%
Gross Profit Growth Q	-32.66%
Gross Profit Growth3 Y	-30.9%
Gross Profit Growth5 Y	-27.83%
Net Income	EUR -10.5M
Pretax Margin	-1,846.78%
Profit Per Employee	EUR -807,683
ROA	-72.68
Roa5y	-70.77
ROCE	250.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.94%
Cagr3y	-46.06%
Cagr5y	-61.08%
Revenue Growth	-75.16x
Revenue Growth Q	-32.66x
Revenue Growth3 Y	-30.9x
Revenue Growth5 Y	-27.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.07
Assets	EUR 7.2M
Cash	EUR 2.1M
Current Assets	EUR 4.3M
Current Liabilities	EUR 11M
Debt	EUR 11.2M
Debt FCF	EUR -1.4
Equity	EUR -21.8M
Interest Coverage	-3.83
Liabilities	EUR 29M
Long Term Assets	EUR 2.9M
Long Term Liabilities	EUR 18M
Net Cash	EUR -9.1M
Net Cash By Market Cap	EUR -55.83
Tangible Book Value	EUR -21.8M
Tangible Book Value Per Share	EUR -0.1
WACC	12.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.39
Net Working Capital	EUR -5.6M
Quick ratio	0.32
Working Capital	EUR -6.7M
Working Capital Turnover	EUR -0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-54.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.91%
200-day SMA	0.11
3Y total return	-84.31%
50-day SMA	0.09
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.11%
All Time High	9.99
All Time High Change	-99.2%
All Time High Date	2021-05-25
All Time Low	0.08
All Time Low Change	3.9%
All Time Low Date	2026-01-29
ATR	0
Beta	0.7
Ch YTD	-22.93
High	0.08
High52	0.27
High52 Date	2025-05-26
High52ch	-69.92%
Low	0.08
Low52	0.08
Low52 Date	2026-02-03
Low52ch	3.9%
Ma50ch	-6.21%
Price vs 200-day SMA	-29.14%
RSI	40.57
RSI Monthly	28.95
RSI Weekly	35.41
Sharpe ratio	-0.78x
Sortino ratio	-1.25
Total Return	-54.91%
Tr YTD	-22.93
Tr1m	-8.68%
Tr1w	-3.85%
Tr3m	1.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -9.6M
Operating margin	-1,695.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	159,562,578%
Net Borrowing	-1,084,749.7
Shares Institutions	10.12%
Shares Qo Q	31.29%
Shares Yo Y	54.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8.3M
Average Volume	13,096.3x
Bv Per Share	-0.1
CAPEX	EUR -3,489
Ch1m	-8.68
Ch1w	-3.85
Ch1y	-64.91
Ch3m	1.52
Ch3y	-84.31
Ch5y	-99.11
Ch6m	-38.93
Change	0.5%
Change From Open	-0.74
Close	0.08
Days Gap	1.26
Depreciation Amortization	64,012.3
Dollar Volume	275.9
Earnings Date	2026-09-29
EBIT	EUR -9.6M
EBITDA	EUR -9.6M
EPS	EUR -0.07
F Score	2
FCF	EUR -8M
FCF EV Yield	-31.57x
Financing CF	7,796,397
Fiscal Year End	December
Founded	2,012
Income Tax	EUR -4,362
Investing CF	157,027
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	0.1
Ma150ch	-20.32%
Ma20	0.08
Ma20ch	-2.44%
Net CF	-41,874
Next Earnings Date	2026-09-29
Open	0.08
Position In Range	14.29
Ppne	369,368.5
Price Date	2026-05-08
Relative Volume	0.26x
Revenue	568,787x
SBC By Revenue	59.97x
Share Based Comp	341,098
Tax By Revenue	-0.77x
Tr6m	-38.93%
Volume	3,449
Z Score	-7.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RIM pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RIM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RIM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+54.9%

Negative means the company is buying back shares.

Technical

LON/0RIM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.6

Neutral momentum band

Price vs 200-day MA

-29.1%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

-0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RIM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RIM stock rating?

lon/0RIM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RIM analysis?

The full report lives at /stocks/lon/0RIM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RIM?

The latest report frames lon/0RIM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RIM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.